The study will involve 1,000 participants with a history of psychosis, and take place across 35 centers (mainly) in Europe and North America.
Analytical Cannabis caught up with Harold Han, founder and chief science officer at the Oakland-based infusion technology company Vertosa, to hear the latest developments from the world of cannabis emulsion research.
The clarification was made to the lawyer Rod Kight, who wrote to the DEA in August 2022, asking for the administration’s stance on the popular THC compounds.
The leading US testing standards organization ASTM International is developing two new testing standards for cannabis samples.
To learn more about what CBD regulations and the market looks like now in 2023, Analytical Cannabis spoke to Dr. Parveen Bhatarah, the regulatory and compliance associate at the ACI.
In a press notice published on February 9, William Tong, the attorney general, also announced that he was in the process of sending warning letters to all Connecticut retailers licensed to sell electronic vapes.
Less legal cannabis was bought in Oregon in 2022 than in 2021. That’s the main finding of a new report from the Oregon Liquor and Cannabis Commission.
Analytical Cannabis recently spoke with Ananda’s Head of Plant Science, Dr. Nigel Gale, to learn more about this research and the advantages that a seed-based cultivation strategy could have for cultivators.
The Canadian cannabis regulator has recalled 1,632 pre-roll products because they were incorrectly labeled.